Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Vikram Purohit is an analyst at Morgan Stanley. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/07/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/03/2024 | ABSI | Buy Now | Absci | $3.46 | 102.31% | → $7 | Initiates | → Overweight | Get Alert |
| 05/16/2024 | ASND | Buy Now | Ascendis Pharma | $136.46 | 2.59% | $116 → $140 | Maintains | Equal-Weight | Get Alert |
| 04/29/2024 | AXSM | Buy Now | Axsome Therapeutics | $83.62 | 37.53% | $90 → $115 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/22/2024 | EXAI | Buy Now | Exscientia | $5.51 | 27.14% | $7 → $7 | Maintains | Equal-Weight | Get Alert |
| 04/22/2024 | ASND | Buy Now | Ascendis Pharma | $136.46 | -14.99% | $116 → $116 | Maintains | Equal-Weight | Get Alert |
| 04/11/2024 | ABVX | Buy Now | Abivax | $13.57 | 17.91% | $15 → $16 | Maintains | Equal-Weight | Get Alert |
| 04/01/2024 | CMPS | Buy Now | Compass Pathways | $6.25 | 380% | → $30 | Initiates | → Overweight | Get Alert |
| 02/28/2024 | SAGE | Buy Now | Sage Therapeutics | $10.94 | 101.1% | $20 → $22 | Maintains | Equal-Weight | Get Alert |
| 12/26/2023 | HALO | Buy Now | Halozyme Therapeutics | $52.58 | 12.21% | $61 → $59 | Maintains | Overweight | Get Alert |
| 11/29/2023 | SLRN | Buy Now | Acelyrin | $4.68 | 177.78% | $19 → $13 | Maintains | Equal-Weight | Get Alert |
| 11/14/2023 | ABVX | Buy Now | Abivax | $13.57 | 10.54% | → $15 | Initiates | → Equal-Weight | Get Alert |
| 11/13/2023 | FHTX | Buy Now | Foghorn Therapeutics | $5.00 | 20% | $10 → $6 | Maintains | Equal-Weight | Get Alert |
| 11/09/2023 | ASND | Buy Now | Ascendis Pharma | $136.46 | -14.99% | $113 → $116 | Maintains | Equal-Weight | Get Alert |
| 11/07/2023 | VTYX | Buy Now | Ventyx Biosciences | $2.29 | 162.02% | $46 → $6 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/01/2023 | INCY | Buy Now | Incyte | $58.17 | 10.02% | $74 → $64 | Maintains | Equal-Weight | Get Alert |
| 10/11/2023 | EXAI | Buy Now | Exscientia | $5.51 | 27.14% | $14 → $7 | Maintains | Equal-Weight | Get Alert |
| 09/13/2023 | SLRN | Buy Now | Acelyrin | $4.68 | 305.98% | $39 → $19 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 09/06/2023 | ASND | Buy Now | Ascendis Pharma | $136.46 | -17.19% | $109 → $113 | Maintains | Equal-Weight | Get Alert |
| 09/05/2023 | SLRN | Buy Now | Acelyrin | $4.68 | 733.33% | $29 → $39 | Maintains | Overweight | Get Alert |
| 08/29/2023 | RGNX | Buy Now | Regenxbio | $10.63 | 295.11% | $43 → $42 | Maintains | Overweight | Get Alert |
| 08/10/2023 | HALO | Buy Now | Halozyme Therapeutics | $52.58 | 16.01% | $60 → $61 | Maintains | Overweight | Get Alert |
| 08/09/2023 | SAGE | Buy Now | Sage Therapeutics | $10.94 | 82.82% | $49 → $20 | Maintains | Equal-Weight | Get Alert |
| 08/07/2023 | ASND | Buy Now | Ascendis Pharma | $136.46 | -20.12% | $109 → $109 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 08/03/2023 | SAGE | Buy Now | Sage Therapeutics | $10.94 | 347.9% | $49 → $49 | Maintains | Equal-Weight | Get Alert |
| 08/02/2023 | INCY | Buy Now | Incyte | $58.17 | 27.21% | $74 → $74 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 08/01/2023 | EXAI | Buy Now | Exscientia | $5.51 | 154.27% | $14 → $14 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 08/01/2023 | ASND | Buy Now | Ascendis Pharma | $136.46 | -20.12% | $109 → $109 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/31/2023 | EXAI | Buy Now | Exscientia | $5.51 | 154.27% | $14 → $14 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/31/2023 | ASND | Buy Now | Ascendis Pharma | $136.46 | -20.12% | $109 → $109 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/26/2023 | EVLO | Buy Now | Evelo Biosciences | $0.00 | 9999900% | $2 → $10 | Maintains | Equal-Weight | Get Alert |
| 07/24/2023 | EXAI | Buy Now | Exscientia | $5.51 | 154.27% | $14 → $14 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/24/2023 | ASND | Buy Now | Ascendis Pharma | $136.46 | -20.12% | $109 → $109 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/20/2023 | INCY | Buy Now | Incyte | $58.17 | 27.21% | $74 → $74 | Reiterates | Underweight → Underweight | Get Alert |
| 07/20/2023 | EXAI | Buy Now | Exscientia | $5.51 | 154.27% | $14 → $14 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/17/2023 | EXAI | Buy Now | Exscientia | $5.51 | 154.27% | $14 → $14 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/17/2023 | ASND | Buy Now | Ascendis Pharma | $136.46 | -20.12% | $109 → $109 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/13/2023 | RXRX | Buy Now | Recursion Pharmaceuticals | $7.48 | 47.14% | $8 → $11 | Maintains | Equal-Weight | Get Alert |
| 07/06/2023 | FHTX | Buy Now | Foghorn Therapeutics | $5.00 | 100% | $13 → $10 | Maintains | Equal-Weight | Get Alert |
| 06/26/2023 | SLRN | Buy Now | Acelyrin | $4.68 | 519.66% | $29 → $29 | Maintains | Overweight | Get Alert |
| 06/26/2023 | EXAI | Buy Now | Exscientia | $5.51 | 154.27% | $14 → $14 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/26/2023 | ASND | Buy Now | Ascendis Pharma | $136.46 | -20.12% | $109 → $109 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/21/2023 | SLRN | Buy Now | Acelyrin | $4.68 | 519.66% | → $29 | Reiterates | Overweight → Overweight | Get Alert |
| 06/20/2023 | EXAI | Buy Now | Exscientia | $5.51 | 154.27% | → $14 | Reiterates | → Equal-Weight | Get Alert |
| 06/20/2023 | ASND | Buy Now | Ascendis Pharma | $136.46 | -20.12% | → $109 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/12/2023 | EXAI | Buy Now | Exscientia | $5.51 | 154.27% | → $14 | Reiterates | → Equal-Weight | Get Alert |
| 06/12/2023 | AXSM | Buy Now | Axsome Therapeutics | $83.62 | 7.63% | $87 → $90 | Maintains | Equal-Weight | Get Alert |
| 06/12/2023 | ASND | Buy Now | Ascendis Pharma | $136.46 | -20.12% | → $109 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/05/2023 | HOOK | Buy Now | HOOKIPA Pharma | $0.52 | 332.69% | $2 → $2.25 | Maintains | Equal-Weight | Get Alert |
| 05/30/2023 | SLRN | Buy Now | Acelyrin | $4.68 | 519.66% | → $29 | Initiates | → Overweight | Get Alert |
| 05/10/2023 | HALO | Buy Now | Halozyme Therapeutics | $52.58 | 14.11% | $64 → $60 | Maintains | Overweight | Get Alert |
| 05/09/2023 | SAGE | Buy Now | Sage Therapeutics | $10.94 | 347.9% | $50 → $49 | Maintains | Equal-Weight | Get Alert |
| 05/09/2023 | RGNX | Buy Now | Regenxbio | $10.63 | 304.52% | $46 → $43 | Maintains | Overweight | Get Alert |
| 05/09/2023 | AXSM | Buy Now | Axsome Therapeutics | $83.62 | 4.04% | $83 → $87 | Maintains | Equal-Weight | Get Alert |
| 05/03/2023 | INCY | Buy Now | Incyte | $58.17 | 27.21% | $77 → $74 | Maintains | Underweight | Get Alert |
| 04/28/2023 | ASND | Buy Now | Ascendis Pharma | $136.46 | -20.12% | $107 → $109 | Maintains | Equal-Weight | Get Alert |
| 04/12/2023 | INCY | Buy Now | Incyte | $58.17 | 32.37% | $76 → $77 | Maintains | Equal-Weight | Get Alert |
| 04/12/2023 | AXSM | Buy Now | Axsome Therapeutics | $83.62 | -0.74% | $85 → $83 | Maintains | Equal-Weight | Get Alert |
| 04/10/2023 | EXAI | Buy Now | Exscientia | $5.51 | 154.27% | $15 → $14 | Maintains | Equal-Weight | Get Alert |
| 04/04/2023 | ASND | Buy Now | Ascendis Pharma | $136.46 | -20.86% | $151 → $108 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 03/06/2023 | RGNX | Buy Now | Regenxbio | $10.63 | 332.74% | $50 → $46 | Maintains | Overweight | Get Alert |
| 03/06/2023 | HALO | Buy Now | Halozyme Therapeutics | $52.58 | 21.72% | $65 → $64 | Maintains | Overweight | Get Alert |
| 03/01/2023 | ARQT | Buy Now | Arcutis Biotherapeutics | $10.24 | 388.29% | $51 → $50 | Maintains | Overweight | Get Alert |
| 02/28/2023 | AXSM | Buy Now | Axsome Therapeutics | $83.62 | 1.65% | $86 → $85 | Maintains | Equal-Weight | Get Alert |
| 02/23/2023 | TALS | Buy Now | Talaris Therapeutics | — | — | $60 → $30 | Maintains | Equal-Weight | Get Alert |
| 02/17/2023 | ASND | Buy Now | Ascendis Pharma | $136.46 | 10.66% | $148 → $151 | Maintains | Overweight | Get Alert |
| 02/15/2023 | EVLO | Buy Now | Evelo Biosciences | $0.00 | 1999900% | $80 → $40 | Maintains | Equal-Weight | Get Alert |
| 01/25/2023 | AKLI | Buy Now | Akili | $0.43 | 597.84% | $2 → $3 | Maintains | Equal-Weight | Get Alert |
| 12/28/2022 | AKLI | Buy Now | Akili | $0.43 | 365.22% | → $2 | Initiates | → Equal-Weight | Get Alert |
| 12/21/2022 | HALO | Buy Now | Halozyme Therapeutics | $52.58 | 23.62% | $53 → $65 | Maintains | Overweight | Get Alert |
| 12/19/2022 | KYMR | Buy Now | Kymera Therapeutics | $33.42 | 22.68% | $38 → $41 | Maintains | Equal-Weight | Get Alert |
| 12/13/2022 | ARQT | Buy Now | Arcutis Biotherapeutics | $10.24 | 398.05% | $49 → $51 | Maintains | Overweight | Get Alert |
| 12/12/2022 | TIL | Buy Now | Instil Bio | $10.33 | -80.64% | $120 → $40 | Maintains | Equal-Weight | Get Alert |
| 11/29/2022 | AXSM | Buy Now | Axsome Therapeutics | $83.62 | 2.85% | $73 → $86 | Maintains | Equal-Weight | Get Alert |
| 11/21/2022 | SAGE | Buy Now | Sage Therapeutics | $10.94 | 357.04% | $53 → $50 | Maintains | Equal-Weight | Get Alert |
| 11/21/2022 | RGNX | Buy Now | Regenxbio | $10.63 | 370.37% | $52 → $50 | Maintains | Overweight | Get Alert |
| 11/21/2022 | FHTX | Buy Now | Foghorn Therapeutics | $5.00 | 180% | $15 → $14 | Maintains | Equal-Weight | Get Alert |
| 11/15/2022 | ASND | Buy Now | Ascendis Pharma | $136.46 | 8.46% | $146 → $148 | Maintains | Overweight | Get Alert |
| 11/10/2022 | PROK | Buy Now | ProKidney | $2.19 | 493.61% | → $13 | Initiates | → Equal-Weight | Get Alert |
| 11/08/2022 | AXSM | Buy Now | Axsome Therapeutics | $83.62 | -12.7% | $74 → $73 | Maintains | Equal-Weight | Get Alert |
| 11/04/2022 | SDGR | Buy Now | Schrodinger | $21.19 | 79.33% | $39 → $38 | Maintains | Equal-Weight | Get Alert |
| 11/04/2022 | KYMR | Buy Now | Kymera Therapeutics | $33.42 | 13.7% | $37 → $38 | Maintains | Equal-Weight | Get Alert |
| 11/03/2022 | ASND | Buy Now | Ascendis Pharma | $136.46 | 6.99% | $148 → $146 | Maintains | Overweight | Get Alert |
| 11/02/2022 | INCY | Buy Now | Incyte | $58.17 | 32.37% | $76 → $77 | Maintains | Equal-Weight | Get Alert |
| 11/01/2022 | TIL | Buy Now | Instil Bio | $10.33 | -41.91% | $160 → $120 | Maintains | Equal-Weight | Get Alert |
| 10/14/2022 | AXSM | Buy Now | Axsome Therapeutics | $83.62 | -11.5% | $71 → $74 | Maintains | Equal-Weight | Get Alert |
| 10/04/2022 | ARQT | Buy Now | Arcutis Biotherapeutics | $10.24 | 378.52% | $46 → $49 | Maintains | Overweight | Get Alert |
| 09/30/2022 | AXSM | Buy Now | Axsome Therapeutics | $83.62 | -15.09% | $75 → $71 | Maintains | Equal-Weight | Get Alert |
| 09/27/2022 | ARQT | Buy Now | Arcutis Biotherapeutics | $10.24 | 349.22% | $45 → $46 | Maintains | Overweight | Get Alert |
| 09/09/2022 | TALS | Buy Now | Talaris Therapeutics | — | — | $80 → $60 | Maintains | Equal-Weight | Get Alert |
| 09/09/2022 | SDGR | Buy Now | Schrodinger | $21.19 | 84.05% | $33 → $39 | Maintains | Equal-Weight | Get Alert |
| 09/09/2022 | RGNX | Buy Now | Regenxbio | $10.63 | 389.18% | $46 → $52 | Maintains | Overweight | Get Alert |
| 09/09/2022 | EXAI | Buy Now | Exscientia | $5.51 | 172.44% | $18 → $15 | Maintains | Equal-Weight | Get Alert |
| 09/09/2022 | EVLO | Buy Now | Evelo Biosciences | $0.00 | 3999900% | $100 → $80 | Maintains | Equal-Weight | Get Alert |
| 08/30/2022 | AXSM | Buy Now | Axsome Therapeutics | $83.62 | -10.31% | $55 → $75 | Maintains | Equal-Weight | Get Alert |
| 08/29/2022 | KYMR | Buy Now | Kymera Therapeutics | $33.42 | 10.71% | $35 → $37 | Maintains | Equal-Weight | Get Alert |
| 08/24/2022 | SDGR | Buy Now | Schrodinger | $21.19 | 55.73% | $34 → $33 | Maintains | Equal-Weight | Get Alert |
| 08/24/2022 | TIL | Buy Now | Instil Bio | $10.33 | -22.54% | $180 → $160 | Maintains | Equal-Weight | Get Alert |
| 08/24/2022 | EXAI | Buy Now | Exscientia | $5.51 | 226.92% | $20 → $18 | Maintains | Equal-Weight | Get Alert |
| 08/24/2022 | EVLO | Buy Now | Evelo Biosciences | $0.00 | 4999900% | $120 → $100 | Maintains | Equal-Weight | Get Alert |
| 08/24/2022 | CERT | Buy Now | Certara | $14.30 | 39.86% | $24 → $20 | Maintains | Equal-Weight | Get Alert |
| 08/24/2022 | FHTX | Buy Now | Foghorn Therapeutics | $5.00 | 200% | $25 → $15 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/11/2022 | ASND | Buy Now | Ascendis Pharma | $136.46 | 8.46% | $152 → $148 | Maintains | Overweight | Get Alert |
| 08/10/2022 | RGNX | Buy Now | Regenxbio | $10.63 | 332.74% | $47 → $46 | Maintains | Overweight | Get Alert |
| 08/10/2022 | AXSM | Buy Now | Axsome Therapeutics | $83.62 | -34.23% | $54 → $55 | Maintains | Equal-Weight | Get Alert |
| 08/03/2022 | INCY | Buy Now | Incyte | $58.17 | 30.65% | $77 → $76 | Maintains | Equal-Weight | Get Alert |
| 08/02/2022 | ARQT | Buy Now | Arcutis Biotherapeutics | $10.24 | 339.46% | $39 → $45 | Maintains | Overweight | Get Alert |
| 07/25/2022 | TBPH | Buy Now | Theravance Biopharma | $8.84 | 13.12% | $11 → $10 | Maintains | Underweight | Get Alert |
| 07/08/2022 | AXSM | Buy Now | Axsome Therapeutics | $83.62 | -35.42% | $27 → $54 | Maintains | Equal-Weight | Get Alert |
| 07/05/2022 | TALS | Buy Now | Talaris Therapeutics | — | — | → $80 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 06/13/2022 | EXAI | Buy Now | Exscientia | $5.51 | 263.25% | $21 → $20 | Maintains | Equal-Weight | Get Alert |
| 06/06/2022 | TIL | Buy Now | Instil Bio | $10.33 | -12.86% | $280 → $180 | Maintains | Equal-Weight | Get Alert |
| 05/24/2022 | TALS | Buy Now | Talaris Therapeutics | — | — | $210 → $200 | Maintains | Overweight | Get Alert |
| 05/24/2022 | RGNX | Buy Now | Regenxbio | $10.63 | 342.14% | $51 → $47 | Maintains | Overweight | Get Alert |
| 05/24/2022 | TIL | Buy Now | Instil Bio | $10.33 | 35.55% | $300 → $280 | Maintains | Equal-Weight | Get Alert |
| 05/23/2022 | FHTX | Buy Now | Foghorn Therapeutics | $5.00 | 400% | $26 → $25 | Maintains | Overweight | Get Alert |
| 05/10/2022 | SAGE | Buy Now | Sage Therapeutics | $10.94 | 384.46% | $57 → $53 | Maintains | Equal-Weight | Get Alert |
| 05/06/2022 | CERT | Buy Now | Certara | $14.30 | 67.83% | $25 → $24 | Maintains | Equal-Weight | Get Alert |
| 05/05/2022 | SDGR | Buy Now | Schrodinger | $21.19 | 60.45% | $35 → $34 | Maintains | Equal-Weight | Get Alert |
| 05/05/2022 | INCY | Buy Now | Incyte | $58.17 | 32.37% | $76 → $77 | Maintains | Equal-Weight | Get Alert |
| 05/04/2022 | KYMR | Buy Now | Kymera Therapeutics | $33.42 | 4.73% | $66 → $35 | Maintains | Equal-Weight | Get Alert |
| 04/27/2022 | AXSM | Buy Now | Axsome Therapeutics | $83.62 | -67.71% | $34 → $27 | Maintains | Equal-Weight | Get Alert |
| 04/20/2022 | INCY | Buy Now | Incyte | $58.17 | 30.65% | $73 → $76 | Maintains | Equal-Weight | Get Alert |
| 04/11/2022 | EXAI | Buy Now | Exscientia | $5.51 | 281.41% | $20 → $21 | Maintains | Equal-Weight | Get Alert |
| 03/23/2022 | TALS | Buy Now | Talaris Therapeutics | — | — | $200 → $210 | Maintains | Overweight | Get Alert |
| 03/23/2022 | RGNX | Buy Now | Regenxbio | $10.63 | 379.77% | $50 → $51 | Maintains | Overweight | Get Alert |
| 03/03/2022 | CERT | Buy Now | Certara | $14.30 | 74.83% | $27 → $25 | Maintains | Equal-Weight | Get Alert |
| 03/02/2022 | TBPH | Buy Now | Theravance Biopharma | $8.84 | 24.43% | $10 → $11 | Maintains | Underweight | Get Alert |
| 03/02/2022 | KYMR | Buy Now | Kymera Therapeutics | $33.42 | 97.49% | $68 → $66 | Maintains | Equal-Weight | Get Alert |
| 02/02/2022 | INCY | Buy Now | Incyte | $58.17 | 30.65% | $77 → $76 | Maintains | Equal-Weight | Get Alert |
| 12/15/2021 | FHTX | Buy Now | Foghorn Therapeutics | $5.00 | 420% | — | Maintains | Overweight | Get Alert |
| 12/10/2021 | RDUS | Buy Now | Radius Health | $15.16 | -53.83% | — | Downgrade | Equal-Weight → Underweight | Get Alert |
| 11/19/2021 | SDGR | Buy Now | Schrodinger | $21.19 | 131.24% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/12/2021 | HOOK | Buy Now | HOOKIPA Pharma | $0.52 | 1053.85% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 06/01/2021 | TALS | Buy Now | Talaris Therapeutics | — | — | → $350 | Initiates | → Overweight | Get Alert |
| 05/26/2021 | TIL | Buy Now | Instil Bio | $10.33 | 122.69% | $480 → $460 | Maintains | Equal-Weight | Get Alert |
| 04/13/2021 | TIL | Buy Now | Instil Bio | $10.33 | 132.37% | → $480 | Initiates | → Equal-Weight | Get Alert |
| 08/05/2020 | DBVT | Buy Now | DBV Technologies | $0.80 | 149.38% | $8 → $4 | Maintains | Equal-Weight | Get Alert |
| 03/18/2020 | DBVT | Buy Now | DBV Technologies | $0.80 | 398.75% | $22 → $8 | Maintains | Equal-Weight | Get Alert |
